Furthermore, reduced omentin levels have been linked to diabetes-related microvascular complications; patients with diabetic retinopathy, neuropathy, or nephropathy consistently show significantly lower circulating omentin compared with those without such complications, partly through mechanisms involving downregulation of vascular endothelial growth factor (VEGF). Here, VEGFA is linked to diabetes mellitus.